RU2016146119A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016146119A3 RU2016146119A3 RU2016146119A RU2016146119A RU2016146119A3 RU 2016146119 A3 RU2016146119 A3 RU 2016146119A3 RU 2016146119 A RU2016146119 A RU 2016146119A RU 2016146119 A RU2016146119 A RU 2016146119A RU 2016146119 A3 RU2016146119 A3 RU 2016146119A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014092102 | 2014-04-25 | ||
| JP2014-092102 | 2014-04-25 | ||
| PCT/JP2015/062516 WO2015163447A1 (ja) | 2014-04-25 | 2015-04-24 | ４環性化合物の新規結晶 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2016146119A RU2016146119A (ru) | 2018-05-29 |
| RU2016146119A3 true RU2016146119A3 (ru) | 2018-07-04 |
Family
ID=54332607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016146119A RU2016146119A (ru) | 2014-04-25 | 2015-04-24 | Новый кристалл тетрациклического соединения |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9714229B2 (ru) |
| EP (1) | EP3135671B1 (ru) |
| JP (1) | JP6873698B2 (ru) |
| KR (2) | KR20220042486A (ru) |
| CN (2) | CN113416179A (ru) |
| CA (1) | CA2946268A1 (ru) |
| MX (1) | MX2016013735A (ru) |
| RU (1) | RU2016146119A (ru) |
| WO (1) | WO2015163447A1 (ru) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2441753B1 (en) * | 2009-06-10 | 2016-03-30 | Chugai Seiyaku Kabushiki Kaisha | Tetracyclic compound |
| TWI526441B (zh) | 2010-08-20 | 2016-03-21 | 中外製藥股份有限公司 | 包含四環化合物的組成物 |
| NZ705705A (en) | 2012-09-25 | 2018-08-31 | Chugai Pharmaceutical Co Ltd | Ret inhibitor |
| CN113975243A (zh) | 2014-04-25 | 2022-01-28 | 中外制药株式会社 | 以高用量含有四环性化合物的制剂 |
| TWI803187B (zh) | 2014-08-08 | 2023-05-21 | 日商中外製藥股份有限公司 | 包含４環性化合物的非晶質體之固體分散體及製劑 |
| WO2016114375A1 (ja) | 2015-01-16 | 2016-07-21 | 中外製薬株式会社 | 併用医薬 |
| US11098037B2 (en) | 2017-07-05 | 2021-08-24 | Fresenius Kabi Oncology Ltd. | Process for preparing alectinib or a pharmaceutically acceptable salt thereof |
| CA3104995A1 (en) | 2018-06-29 | 2020-01-02 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition comprising poorly soluble basic agent |
| AU2019337018B2 (en) | 2018-09-04 | 2024-03-07 | Chugai Seiyaku Kabushiki Kaisha | Method of producing tetracyclic compound |
| EP3556754A1 (en) | 2018-12-07 | 2019-10-23 | Fresenius Kabi iPSUM S.r.l. | Process for the preparation of alectinib |
| AR121187A1 (es) | 2019-12-27 | 2022-04-27 | Chugai Pharmaceutical Co Ltd | Método para clasificar, evaluar o fabricar lauril sulfato de sodio de materia prima o formulación farmacéutica que lo contiene |
| EP4285907A1 (en) | 2021-01-29 | 2023-12-06 | Chugai Seiyaku Kabushiki Kaisha | Drug composition for treating pediatric cancers |
| WO2023074785A1 (ja) | 2021-10-28 | 2023-05-04 | 中外製薬株式会社 | シロップ剤 |
| WO2023161233A1 (en) | 2022-02-22 | 2023-08-31 | Synthon B.V. | Solid forms of alectinib and alectinib salts |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0892090A (ja) | 1994-07-26 | 1996-04-09 | Tanabe Seiyaku Co Ltd | 医薬組成物 |
| ES2123873T3 (es) | 1994-08-04 | 1999-01-16 | Hoffmann La Roche | Pirrolocarbazol. |
| CZ347098A3 (cs) | 1996-05-01 | 1999-06-16 | Eli Lilly And Company | Halogenem substituovaná sloučenina jako inhibitor protein kinázy C |
| DE60033649D1 (de) | 1999-05-14 | 2007-04-12 | Australian Nat University Acto | Verbindungen und therapeutische methoden |
| EP1364643A4 (en) | 2000-12-01 | 2009-07-15 | Kyowa Hakko Kogyo Kk | COMPOSITION WITH IMPROVED ORAL SOLUBILITY OR ABSORBABILITY |
| JP2007501857A (ja) | 2003-02-28 | 2007-02-01 | イノテック ファーマシューティカルズ コーポレーション | 四環系ベンズアミド誘導体およびその使用方法 |
| ATE328112T1 (de) | 2003-03-07 | 2006-06-15 | Ist Naz Stud Cura Dei Tumori | Anaplastisches lymphoma kinase testverfahren, reagenzien und kompositionen davon |
| GB0305929D0 (en) | 2003-03-14 | 2003-04-23 | Novartis Ag | Organic compounds |
| AU2004259012C1 (en) | 2003-07-23 | 2012-08-02 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
| US7378414B2 (en) | 2003-08-25 | 2008-05-27 | Abbott Laboratories | Anti-infective agents |
| MXPA06005702A (es) | 2003-11-21 | 2006-08-17 | Novartis Ag | Derivados de 1h-imidazoquinolina como inhibidores de quinasa de proteina. |
| AU2004296905A1 (en) | 2003-12-12 | 2005-06-23 | Merck Frosst Canada Ltd | Cathepsin cysteine protease inhibitors |
| BRPI0508969A (pt) | 2004-03-19 | 2007-08-21 | Speedel Experimenta Ag | compostos orgánicos |
| JP2008502595A (ja) | 2004-03-31 | 2008-01-31 | エグゼリクシス， インコーポレイテッド | 未分化リンパ腫キナーゼモジュレータおよびその使用方法 |
| ATE463486T1 (de) | 2004-08-26 | 2010-04-15 | Pfizer | Enantiomerenreine aminoheteroaryl-verbindungen als proteinkinasehemmer |
| GB0517329D0 (en) | 2005-08-25 | 2005-10-05 | Merck Sharp & Dohme | Stimulation of neurogenesis |
| EP1945633A1 (en) | 2005-11-07 | 2008-07-23 | Irm Llc | Compounds and compositions as ppar modulators |
| US7601716B2 (en) | 2006-05-01 | 2009-10-13 | Cephalon, Inc. | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors |
| US8063225B2 (en) | 2006-08-14 | 2011-11-22 | Chembridge Corporation | Tricyclic compound derivatives useful in the treatment of neoplastic diseases, inflammatory disorders and immunomodulatory disorders |
| CA2598893C (en) | 2006-10-11 | 2012-04-10 | Astellas Pharma Inc. | Eml4-alk fusion gene |
| EP1914240B1 (en) | 2006-10-11 | 2009-12-02 | Astellas Pharma Inc. | EML4-ALK fusion gene |
| CL2007003049A1 (es) | 2006-10-23 | 2008-05-16 | Cephalon Inc Pharmacopeia Drug | Compuestos derivados de 2,4-diaminopirimidina; composicion farmaceutica, utiles para tratar trastornos proliferativos. |
| JP2010524953A (ja) | 2007-04-17 | 2010-07-22 | ブリストル−マイヤーズ スクイブ カンパニー | 縮合ヘテロ環１１−β−ヒドロキシステロイドデヒドロゲナーゼＩ型阻害剤 |
| TWI389893B (zh) | 2007-07-06 | 2013-03-21 | Astellas Pharma Inc | 二（芳胺基）芳基化合物 |
| CN103923072B (zh) | 2007-07-20 | 2017-05-31 | 内尔维阿诺医学科学有限公司 | 作为具有激酶抑制剂活性的取代的吲唑衍生物 |
| WO2009073620A2 (en) | 2007-11-30 | 2009-06-11 | Newlink Genetics | Ido inhibitors |
| EA201190235A1 (ru) | 2009-05-07 | 2012-05-30 | Астразенека Аб | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 |
| EP2441753B1 (en) | 2009-06-10 | 2016-03-30 | Chugai Seiyaku Kabushiki Kaisha | Tetracyclic compound |
| GB0910046D0 (en) | 2009-06-10 | 2009-07-22 | Glaxosmithkline Biolog Sa | Novel compositions |
| US8609097B2 (en) | 2009-06-10 | 2013-12-17 | Hoffmann-La Roche Inc. | Use of an anti-Tau pS422 antibody for the treatment of brain diseases |
| TWI526441B (zh) | 2010-08-20 | 2016-03-21 | 中外製藥股份有限公司 | 包含四環化合物的組成物 |
| JP5006987B2 (ja) | 2010-11-22 | 2012-08-22 | 中外製薬株式会社 | ４環性化合物を含む医薬 |
| NZ705705A (en) * | 2012-09-25 | 2018-08-31 | Chugai Pharmaceutical Co Ltd | Ret inhibitor |
| JP2015185406A (ja) | 2014-03-25 | 2015-10-22 | トヨタ自動車株式会社 | 燃料電池システム及び燃料電池の水分量制御方法 |
-
2015
- 2015-04-24 US US15/126,045 patent/US9714229B2/en active Active
- 2015-04-24 JP JP2016515222A patent/JP6873698B2/ja active Active
- 2015-04-24 EP EP15782464.0A patent/EP3135671B1/en active Active
- 2015-04-24 KR KR1020227009664A patent/KR20220042486A/ko not_active Application Discontinuation
- 2015-04-24 WO PCT/JP2015/062516 patent/WO2015163447A1/ja active Application Filing
- 2015-04-24 CN CN202110843684.1A patent/CN113416179A/zh active Pending
- 2015-04-24 KR KR1020167031032A patent/KR20160142383A/ko not_active Application Discontinuation
- 2015-04-24 MX MX2016013735A patent/MX2016013735A/es unknown
- 2015-04-24 CA CA2946268A patent/CA2946268A1/en active Pending
- 2015-04-24 CN CN201580020748.0A patent/CN106458967A/zh active Pending
- 2015-04-24 RU RU2016146119A patent/RU2016146119A/ru unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN113416179A (zh) | 2021-09-21 |
| US20170081306A1 (en) | 2017-03-23 |
| WO2015163447A1 (ja) | 2015-10-29 |
| JPWO2015163447A1 (ja) | 2017-04-20 |
| JP6873698B2 (ja) | 2021-05-19 |
| EP3135671A4 (en) | 2017-11-22 |
| MX2016013735A (es) | 2017-03-09 |
| RU2016146119A (ru) | 2018-05-29 |
| CA2946268A1 (en) | 2015-10-29 |
| US9714229B2 (en) | 2017-07-25 |
| EP3135671B1 (en) | 2019-09-18 |
| CN106458967A (zh) | 2017-02-22 |
| KR20220042486A (ko) | 2022-04-05 |
| KR20160142383A (ko) | 2016-12-12 |
| EP3135671A1 (en) | 2017-03-01 |